Burlington, Massachusetts-based Coronado Biosciences, Inc., (CNDO), is a clinical stage biopharmaceutical company that develops immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. Coronado was founded in 2006.
This 230M market cap company's lead pharmaceutical product candidates are:
TSO (Trichuris suis ova or...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|